Hansoh Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Hansoh Pharmaceutical Group has a total shareholder equity of CN¥27.9B and total debt of CN¥40.3M, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are CN¥31.7B and CN¥3.8B respectively. Hansoh Pharmaceutical Group's EBIT is CN¥4.2B making its interest coverage ratio -4.1. It has cash and short-term investments of CN¥23.5B.
Key information
0.1%
Debt to equity ratio
CN¥40.26m
Debt
| Interest coverage ratio | -4.1x |
| Cash | CN¥23.50b |
| Equity | CN¥27.90b |
| Total liabilities | CN¥3.77b |
| Total assets | CN¥31.67b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 3692's short term assets (CN¥27.4B) exceed its short term liabilities (CN¥3.4B).
Long Term Liabilities: 3692's short term assets (CN¥27.4B) exceed its long term liabilities (CN¥336.6M).
Debt to Equity History and Analysis
Debt Level: 3692 has more cash than its total debt.
Reducing Debt: 3692's debt to equity ratio has increased from 0% to 0.1% over the past 5 years.
Debt Coverage: 3692's debt is well covered by operating cash flow (11558%).
Interest Coverage: 3692 earns more interest than it pays, so coverage of interest payments is not a concern.